ETFis Series Trust I (BBP)
Verwaltungsgesellschaft · ARCX · Serie S000047354 · Auf SEC EDGAR ansehen ↗
- Nettovermögen
- $59.3M
- Bestände
- 63
- Stand
- 30. April 2026 veraltet
- Gewichtung der Top-10-Positionen
- 26,74%
- Effektive Anzahl von Positionen
- 51,3
- Positionen über 1%
- 57
Auf dieser Seite
- Fondstransaktionen Geld, das jeden Monat in den Fonds fließt und aus ihm abfließt, aus N-PORT-Einreichungen.
- Bestände Jede Position, die der Fonds derzeit hält, mit Gewichtungen.
- Sektoraufschlüsselung Aufteilung der Fondsbestände nach Sektoren.
- Institutionelle Eigentümer 13F-Institutionen, die angeben, diesen ETF zu halten.
- Ähnliche Fonds Andere Fonds mit überlappenden Beständen oder vergleichbarer Größe.
Fondsflüsse (SEC-gemeldet)
- Letzter Monat (Apr 2026)
- +$4.3M
- Quartalsende Apr 2026
- +$12.4M
- Letzte 12 Monate
- +$24.1M
Mai 2025 – Apr 2026
Based on the fund's own SEC Form N-PORT monthly flow disclosures (Item C.9 "Flow Information") — sales minus redemptions, reinvested distributions excluded. This is a different, independent metric from the "Net flows" estimate above (which is derived from daily shares-outstanding changes). SEC N-PORT filing lag is up to ~60 days; the most recent month/quarter may not yet be fully reflected.
Vollständige Zusammensetzung 63 Beteiligungen
| Name | CUSIP | Wert | % | Bilanz | Kategorie | Land |
|---|---|---|---|---|---|---|
| IMMUNITYBIO INC | 45256X103 | $2.8M | 4,80 | 401.005 | EC | US |
| DREYFUS GOVERNMENT CASH MANAGE | — | $1.9M | 3,15 | 1.868.134 | STIV | US |
| APELLIS PHARMACEUTICALS INC | 03753U106 | $1.5M | 2,59 | 37.509 | EC | US |
| KALVISTA PHARMACEUTICALS INC | 483497103 | $1.5M | 2,52 | 55.964 | EC | US |
| MODERNA INC | 60770K107 | $1.5M | 2,49 | 32.122 | EC | US |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | $1.4M | 2,44 | 430.167 | EC | US |
| MIRUM PHARMACEUTICALS INC | 604749101 | $1.4M | 2,39 | 14.558 | EC | US |
| AXSOME THERAPEUTICS INC | 05464T104 | $1.3M | 2,24 | 6.386 | EC | US |
| KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | — | $1.2M | 2,06 | 22.754 | EC | GB |
| ROIVANT SCIENCES LTD | — | $1.2M | 2,06 | 42.821 | EC | BM |
| ZAI LAB LTD | 98887Q104 | $1.2M | 1,94 | 53.256 | EC | KY |
| LIGAND PHARMACEUTICALS | 53220K504 | $1.1M | 1,93 | 4.992 | EC | US |
| BIOCRYST PHARMACEUTICALS INC | 09058V103 | $1.1M | 1,93 | 125.015 | EC | US |
| TRAVERE THERAPEUTICS INC | 89422G107 | $1.1M | 1,93 | 27.170 | EC | US |
| NOVAVAX INC | 670002401 | $1.1M | 1,93 | 144.044 | EC | US |
| UNITED THERAPEUTICS CORP | 91307C102 | $1.1M | 1,84 | 1.914 | EC | US |
| GERON CORP | 374163103 | $1.1M | 1,81 | 695.861 | EC | US |
| BIONTECH SE | 09075V102 | $1.0M | 1,74 | 9.981 | EC | DE |
| AMGEN INC | 031162100 | $1.0M | 1,74 | 2.977 | EC | US |
| EXELIXIS INC | 30161Q104 | $1.0M | 1,74 | 23.148 | EC | US |
| BIOGEN INC | 09062X103 | $1.0M | 1,73 | 5.434 | EC | US |
| GILEAD SCIENCES INC | 375558103 | $1.0M | 1,73 | 7.859 | EC | US |
| TG THERAPEUTICS INC | 88322Q108 | $1.0M | 1,72 | 30.187 | EC | US |
| KRYSTAL BIOTECH INC | 501147102 | $1.0M | 1,71 | 3.866 | EC | US |
| LEGEND BIOTECH CORP | 52490G102 | $997K | 1,68 | 42.398 | EC | KY |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | $996K | 1,68 | 46.457 | EC | US |
| ARROWHEAD PHARMACEUTICALS INC | 04280A100 | $992K | 1,67 | 13.501 | EC | US |
| ASCENDIS PHARMA A/S | 04351P101 | $985K | 1,66 | 4.293 | EC | DK |
| AGIOS PHARMACEUTICALS INC | 00847X104 | $972K | 1,64 | 34.703 | EC | US |
| HALOZYME THERAPEUTICS INC | 40637H109 | $968K | 1,63 | 15.211 | EC | US |
| ARDELYX INC | 039697107 | $965K | 1,63 | 152.393 | EC | US |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | $957K | 1,61 | 17.750 | EC | US |
| INCYTE CORP | 45337C102 | $945K | 1,59 | 9.918 | EC | US |
| AURINIA PHARMACEUTICALS INC | 05156V102 | $919K | 1,55 | 59.707 | EC | CA |
| SAREPTA THERAPEUTICS INC | 803607100 | $918K | 1,55 | 43.955 | EC | US |
| REGENERON PHARMACEUTICALS | 75886F107 | $902K | 1,52 | 1.276 | EC | US |
| BRIDGEBIO PHARMA INC | 10806X102 | $895K | 1,51 | 12.592 | EC | US |
| VERTEX PHARMACEUTICALS INC | 92532F100 | $895K | 1,51 | 2.093 | EC | US |
| BEONE MEDICINES LTD | 07725L102 | $875K | 1,48 | 2.965 | EC | CH |
| IONIS PHARMACEUTICALS INC | 462222100 | $875K | 1,48 | 11.708 | EC | US |
| CRISPR THERAPEUTICS AG | — | $874K | 1,47 | 16.695 | EC | CH |
| THERAVANCE BIOPHARMA INC | — | $872K | 1,47 | 52.082 | EC | KY |
| MADRIGAL PHARMACEUTICALS INC | 558868105 | $856K | 1,44 | 1.655 | EC | US |
| KURA ONCOLOGY INC | 50127T109 | $818K | 1,38 | 92.599 | EC | US |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | $815K | 1,38 | 6.192 | EC | US |
| PTC THERAPEUTICS INC | 69366J200 | $814K | 1,37 | 12.510 | EC | US |
| ACADIA PHARMACEUTICALS INC | 004225108 | $782K | 1,32 | 34.855 | EC | US |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | $757K | 1,28 | 32.610 | EC | US |
| TARSUS PHARMACEUTICALS INC | 87650L103 | $740K | 1,25 | 11.632 | EC | US |
| ALNYLAM PHARMACEUTICALS INC | 02043Q107 | $736K | 1,24 | 2.379 | EC | US |
Seite 1
von 2
← Zurück
Weiter →
Sektoraufschlüsselung
Healthcare
90,0%
Sonstige/Nicht zugeordnet
10,0%
Institutionelle Eigentümer (13F) 28 Einreicher
Institutionen, die diese ETF in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann zweimal für separate Optionskontrakte erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
| Institution | Wert | % der verfolgten 13F | Aktien | Typ | Stand |
|---|---|---|---|---|---|
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $10.464.537 | 29,64% | 104.374 | Aktien | 30. Juni 2026 |
| ROYAL BANK OF CANADA | $8.916.000 | 25,26% | 92.620 | Aktien | 30. Juni 2026 |
| CWA Asset Management Group, LLC | $1.791.174 | 5,07% | 18.606 | Aktien | 30. Juni 2026 |
| ENVESTNET ASSET MANAGEMENT INC | $1.755.458 | 4,97% | 18.235 | Aktien | 30. Juni 2026 |
| Cetera Investment Advisers | $1.702.510 | 4,82% | 17.685 | Aktien | 30. Juni 2026 |
| TWO SIGMA INVESTMENTS, LP | $1.636.566 | 4,64% | 17.000 | Aktien | 30. Juni 2026 |
| WBI INVESTMENTS, LLC | $1.613.080 | 4,57% | 16.756 | Aktien | 30. Juni 2026 |
| LPL Financial LLC | $1.243.501 | 3,52% | 12.917 | Aktien | 30. Juni 2026 |
| Prime Capital Investment Advisors, LLC | $1.146.945 | 3,25% | 11.914 | Aktien | 30. Juni 2026 |
| MORGAN STANLEY | $1.094.574 | 3,10% | 11.370 | Aktien | 30. Juni 2026 |
| Advisor Resource Council | $1.068.550 | 3,03% | 10.761 | Aktien | 30. Juni 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.037.487 | 2,94% | 10.777 | Aktien | 30. Juni 2026 |
| INDEPENDENT FINANCIAL GROUP, LLC | $719.704 | 2,04% | 7.476 | Aktien | 30. Juni 2026 |
| Kestra Advisory Services, LLC | $400.472 | 1,13% | 4.160 | Aktien | 30. Juni 2026 |
| RAYMOND JAMES FINANCIAL INC | $290.827 | 0,82% | 3.021 | Aktien | 30. Juni 2026 |
| FOUNDERS FINANCIAL SECURITIES LLC | $216.316 | 0,61% | 2.247 | Aktien | 30. Juni 2026 |
| CWM, LLC | $59.556 | 0,17% | 717 | Aktien | 31. März 2026 |
| Institute for Wealth Management, LLC. | $34.272 | 0,10% | 356 | Aktien | 30. Juni 2026 |
| OSAIC HOLDINGS, INC. | $30.124 | 0,09% | 313 | Aktien | 30. Juni 2026 |
| COMERICA BANK | $17.342 | 0,05% | 217 | Aktien | 31. Dezember 2025 |
| FIFTH THIRD BANCORP | $14.537 | 0,04% | 151 | Aktien | 30. Juni 2026 |
| Byrne Asset Management LLC | $13.670 | 0,04% | 142 | Aktien | 30. Juni 2026 |
| Steward Partners Investment Advisory, LLC | $11.071 | 0,03% | 115 | Aktien | 30. Juni 2026 |
| Allworth Financial LP | $6.836 | 0,02% | 71 | Aktien | 30. Juni 2026 |
| Glen Eagle Advisors, LLC | $4.813 | 0,01% | 50 | Aktien | 30. Juni 2026 |
| Thrivent Financial for Lutherans | $4.322 | 0,01% | 44.897 | Aktien | 30. Juni 2026 |
| MERCER GLOBAL ADVISORS INC /ADV | $3.562 | 0,01% | 37 | Aktien | 30. Juni 2026 |
| Farther Finance Advisors, LLC | $2.214 | 0,01% | 23 | Aktien | 30. Juni 2026 |
Vergleichsfonds
Ähnlich in der Größe
| Fonds | AuM |
|---|---|
| FGSM Advisors' Inner Circle Fund II | $59.3M |
| QVOY Ultimus Managers Trust | $59.5M |
| EURL Direxion Shares ETF Trust | $59.6M |
| THLV THOR Financial Technologies Tru… | $59.7M |
| NDIA Global X Funds | $59.8M |
| TMFS RBB Fund, Inc. | $59.2M |
| WBIY Absolute Shares Trust | $59.0M |
| OCTT AIM ETF Products Trust | $58.9M |
| BRKU Direxion Shares ETF Trust | $58.5M |
| JANB ETF Series Solutions | $58.5M |